Anti-Integrin b2ITGB2CD18 Antibody (Erlizumab)

Anti-Integrin b2/ITGB2/CD18 Antibody (Erlizumab)

Author: ApexBio

spu:

F1585

CAS:

211323-03-4

purity:

> 90% by SDS-PAGE and SEC-HPLC analyses.

shortsummary:

Anti-Integrin b2/ITGB2/CD18 Antibody (Erlizumab)

aprotonin site

M.Wt:

145 kDa

Storage:

-80°C

DeliveryTime:

Ship with 3-5 days

pepstatin a protease inhibitor

ShippingType:

Dry ice

description:

Erlizumab is a CHO-expressed humanized antibody targeting Integrin b2/ITGB2/CD18. Erlizumab has a huIgG1-type heavy chain and a huκ-type light chain with a predicted molecular weight (MW) of 145 kDa.

related websites:

APExBIO Technology LLC is a premier provider of Small Molecule Inhibitors/Activators, Compound Libraries, Peptides, Assay Kits, Fluorescent Labels, Enzymes, Modified Nucleotides, mRNA synthesis and various tools for Molecular Biology. We carry a broad product line in over 17909 different research areas such as cancer, immunology, neurosciences, apoptosis and epigenetics etc. Based in USA (Houston, Texas), we have been serving the needs of customers across the world.